CHRISTINE GRANSDEN: Open Payments
NPI 1013563261 · MOUNT PLEASANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 72 payments from 10 companies in 2025. Trend: 2023 $157 · 2024 $623 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $203 |
| ABBVIE INC. | 16 | $202 |
| Janssen Pharmaceuticals, Inc | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 12 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: VRAYLAR, SPRAVATO, FANAPT, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, INGREZZA.
Industry payments across MI — which companies pay providers there.
